Trial
NCT02319889
Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Stage I Non-Small Cell Lung Cancer
Intervention
Stereotactic Body Radiotherapy
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-01